Ipsen S.A.
EPA:IPN.PA
116.8 (EUR) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Ipsen S.A. |
Symbool | IPN.PA |
Munteenheid | EUR |
Prijs | 116.8 |
Beurswaarde | 9,652,260,312 |
Dividendpercentage | 0.99% |
52-weken bereik | 99.7 - 126.7 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. David Loew |
Website | https://www.ipsen.com |
An error occurred while fetching data.
Over Ipsen S.A.
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)